Shlomo Yanai is a Senior Advisor at Moelis & Company. During his nearly 15 years as a corporate executive, Shlomo successfully completed over 20 acquisitions and integrations. Shlomo served (2007 - 2012) as the Chief Executive Officer and President of Teva Pharmaceutical Industries Ltd.
Prior to Teva, he served as the Chief Executive Officer and President of ADAMA Agricultural Solutions Ltd.
Mr. Yanai currently holds board positions at a number of companies and organizations, including his role as Non-Executive Chairman of the Board of Directors at Cambrex, Director of W.R. Grace, Public Limited Company, and Chairman of the Board of Directors of Protalix BioTherapeutics.
Mr. Yanai is a graduate of Tel Aviv University and George Washington University. He is also a graduate of the Advanced Management Program of Harvard Business School and U.S. National War College.